|
MDM4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.09689981728923E-10 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.13389999611968E-08 |
| Normal-vs-Stage2 |
2.80540000008322E-07 |
| Normal-vs-Stage3 |
8.10489453328955E-11 |
| Normal-vs-Stage4 |
7.395300E-04 |
| Stage1-vs-Stage2 |
2.867200E-01 |
| Stage1-vs-Stage3 |
4.860400E-02 |
| Stage1-vs-Stage4 |
8.581800E-01 |
| Stage2-vs-Stage3 |
7.220400E-01 |
| Stage2-vs-Stage4 |
3.969600E-01 |
| Stage3-vs-Stage4 |
2.255200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.9441000465601E-09 |
| Normal-vs-AfricanAmerican |
5.204300E-02 |
| Normal-vs-Asian |
2.845800E-04 |
| Caucasian-vs-AfricanAmerican |
6.444400E-02 |
| Caucasian-vs-Asian |
1.550020E-01 |
| AfricanAmerican-vs-Asian |
5.084400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.1114999999905E-05 |
| Normal-vs-Female |
5.58979529330372E-11 |
| Male-vs-Female |
1.145020E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.81369996377879E-09 |
| Normal-vs-Age(41-60Yrs) |
1.78560000119177E-09 |
| Normal-vs-Age(61-80Yrs) |
2.07240000005271E-06 |
| Normal-vs-Age(81-100Yrs) |
2.715300E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.508600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.302000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.814400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.640400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.308000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.977600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
8.91170000016928E-08 |
| Classical-VS-Follicular |
3.054400E-02 |
| Classical-VS-Other |
6.570600E-01 |
| Classical-VS-Normal |
3.30170000006902E-07 |
| Tall-VS-Follicular |
5.724500E-03 |
| Tall-VS-Other |
4.484200E-02 |
| Tall-VS-Normal |
2.61235477694299E-13 |
| Follicular-VS-Other |
7.945600E-01 |
| Follicular-VS-Normal |
9.40080000511045E-08 |
| Other-VS-Normal |
1.864140E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.37859765006965E-11 |
| Normal-vs-N1 |
7.828500E-04 |
| N0-vs-N1 |
2.647000E-01 |
|
|
